It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Novo Nordisk A/S (NVO) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.83, or 0.42%, to $200.37. The Novo Nordisk A/S has recorded 21,084 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Novo Nordisk A/S – share repurchase programme.
Novo Nordisk A/S is listed on the NYSE in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $199.54 and fluctuated between $201.76 as its day high and $195.00 as its day low. The current market capitalization of Novo Nordisk A/S is $341.35B. A total of 3.91 million shares were traded on the day, compared to an average of 1.56M shares.
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Novo Nordisk A/S pays an annual dividend of $2.06, resulting in a dividend yield of 1.03%, and it has a price to earnings (P/E) ratio of 46.91. NVO’s most recent ex-dividend date was 8/18/2023 when it declared a $0.8836 quarterly dividend that was paid in cash on 8/29/2023. Previously, the company paid the dividend on 4/4/2023 with an ex-dividend date of 3/24/2023. The NVO stock dividend was $1.1887 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for NVO in the last 3 months, the mean price target is $190.91 with high estimates of $235.00 and low estimates of $105.39. In terms of 52-week highs and lows, NVO has a high of $197.54 and a low of $95.02.
As of this writing, NVO has an earnings estimate of $1.25 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $1.34 per share and a lower estimate of $1.17. The company reported an EPS of $0.87 in the last quarter, which was 2.40% higher than expectations of $0.85.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NVO’s latest balance sheet shows that the firm has $17.48B in Cash & Short Term Investments as of fiscal 2021. There were $26.64B in debt and $99.52B in liabilities at the time. Its Book Value Per Share was $5.78, while its Total Shareholder’s Equity was $70.75B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVO is Buy with a score of 4.50.